Lenalidomide provide better progression free survival than thalidomide and bortezomib in the first relapse of multiple myeloma patients after autologous transplantation


Malkan Ü. Y., Buyukasik Y., Demiroglu H., Ciftciler R., Gunes G., Okay M., ...More

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 73
  • City: İstanbul
  • Country: Turkey
  • Hacettepe University Affiliated: Yes